Nina Capital

Nina Capital Overview

In the firm's investment criteria and process, they are informed by a Stanford-born methodology of health technology innovation known as Biodesign. Since 2001, Biodesign has proven to de-risk the process of new venture creation by applying a need-driven and value-based approach to reinventing healthcare with the help of technology. The focal point lies in supporting founders who possess a deep comprehension of the intricate network of healthcare system stakeholders, coupled with significant engineering innovation, advanced data science, and information technology-enabled solutions. Operating primarily from Europe, the firm aim is to identify and assist founders driven by genuine needs, committed to serving these stakeholders on a global scale with effectiveness and efficiency. The firm invests broadly across Europe, including the United Kingdom, in the United States, Canada, Israel, and Australia, with a collaborative approach in how they work and interact with other players in their industry. Their goal is to help thoughtful and committed teams bridge the chasm from founding to series A capital and access global markets.

Latest News

Feb 16, 2022 · www.prnewswire.com

growth-positive

Health Tech VC firm Nina Capital Closes Oversubscribed Second Fund and Announces its First Four Investments

Venture capital firm Nina Capital has announced that its second fund, initiated last fall, has surpassed its target size of EUR40 million in just four months. The fund will be used to continue the firms strategy of investing exclusively in pre-seed to Series A healthcare technology companies based in Europe, the U.S. and Israel. This follows a successful 2021 for Nina Capital, which completed building a portfolio of 23 early-stage healthcare technology companies for its inaugural EUR18M fund. Several of these companies have raised subsequent funding from international investors, and one, Replica Analytics, was acquired by Aetion.

InvestmentAcquisition

Jun 21, 2021 · www.webcapitalriesgo.com

growth-positive

Nina Capital lanza un fondo de €40 millones - Webcapitalriesgo

Venture capital firm Nina Capital has announced the launch of its second fund, which is dedicated to investing in startups. The fund already has €18 million committed and is expected to close its first round in October. The fund was registered with the National Securities Market Commission (CNMV) on June 4. The goal is to raise €40 million. Investors in the fund include health sector companies, family offices, and individual investors, mainly from Italy, Germany, Switzerland, and the United States. The fund will focus on early-stage companies, with investment amounts ranging from €300,000 to €600,000.

Investment

Team Members

3

Web & Social Links

Locations

Spain

Photos & Videos

No files yet

Nina Capital Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info